MOORSIDE PHARMA DEVELOPMENTS LIMITED
ActiveKey figures
Like most small UK companies, MOORSIDE PHARMA DEVELOPMENTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 47730Where the company stands among the 7,549 active companies whose first SIC code is 47730 (Dispensing chemist in specialised stores).
- SUPERDRUG STORES PLC£471.2m
- DAY LEWIS PLC£142.9m
- FEEL GOOD PHARMA LTD£58.9m
- WAREMOSS LIMITED£43.2m
- JARDINES (U.K.) LIMITED£40m
- N & R GORDON LTD£36.7m
- RAMCO (HARLOW) LIMITED£34.9m
- HEALTHNET HOMECARE (UK) LIMITED£31.4m
- L.ROWLAND & COMPANY (RETAIL) LIMITED£31.3m
- MEDEXPRESS ENTERPRISES LTD£29.5m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 7,549. The line on each bar marks the median.
Summary: MOORSIDE PHARMA DEVELOPMENTS LIMITED
What kind of company is it?
MOORSIDE PHARMA DEVELOPMENTS LIMITED is a private limited company registered with Companies House under company number 07930921. It was incorporated on 1 Feb 2012. Its status is active. The registered office is in Bradford (BD2). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), other human health activities (86900).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files micro-entity accounts. Net assets were −£52,522, down 835.6% on the previous year. The company had an average of 7 employees. Figures are available for 6 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 7,549 active companies whose first SIC code is 47730: By net assets it ranks lower than 94% of them (median £54,163). By total assets it ranks higher than 56% of them (median £450,890). By number of employees it ranks higher than 65% of them (median 2). It is older than 69% of them (median age 6.0 years).
Does it supply the public sector?
The company is named as the supplier in one public contract award notice, from Bradford Metropolitan District Council. 1 of the awards is shared with other suppliers, typically framework agreements.
Who runs and controls the company?
The company has 7 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 15 Feb 2027.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 740,104 | 671,603 | 659,656 | 643,642 | 572,697 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | -6,669 | 33,514 | 3,491 | -5,614 | -52,522 |
| Average number of employees | 0 | 6 | 0 | 7 | 7 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Public contracts
1 contractMOORSIDE PHARMA DEVELOPMENTS LIMITED is named as a supplier in 1 public contract award notice from Bradford Metropolitan District Council. 1 award is shared with other suppliers.
- Community Pharmacy Needle and Syringe Programme Framework‡Bradford Metropolitan District Council · shared by 11 suppliers, up to £200,000 in total
From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.
History
17 events- Financial year 2024/25 endedAccounts: net assets −£52.5k, 7 employees
- Financial year 2023/24 endedAccounts: net assets −£5,614, 7 employees
- Financial year 2022/23 endedAccounts: net assets £3,491, 0 employees
- Financial year 2021/22 endedAccounts: net assets £33.5k, 6 employees
- Financial year 2020/21 endedAccounts: net assets −£6,669, 0 employees
- Financial year 2019/20 endedAccounts: net assets −£80.1k, 12 employees
- Rycroft Partnership Llp registered as a person with significant control
- Nicola Ann BOOTH resignedDirector
Earlier events (9)
- Nicola Ann BOOTH appointedDirector
- Andrew John BOYLE appointedDirector
- Steven John CLEASBY appointedDirector
- Jonathan David COLE appointedDirector
- Jonathan Alan DIXON appointedDirector
- Philip HODGSON appointedDirector
- Mahmoud KHODADI appointedDirector
- John Marcus SULLIVAN appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.